(1)
Anas Babar. Comment on Khan S P Khan, Et Al. (J Pak Med Assoc. 74: 1654-1658, September 2024) Role of Oral Hypoglycaemic Drugs in Preventing Complications in Non-Alcoholic Fatty Liver Disease With Type 2 Diabetes Mellitus. J Pak Med Assoc 2025, 75, 349-349.